Isopropylphenidate
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
propan-2-yl 2-phenyl-2-(piperidin-2-yl)acetate
|
|
Clinical data | |
Legal status | |
Identifiers | |
CAS Number | 93148-46-0 |
PubChem | CID: 68314762 |
ChemSpider | 48062090 |
Chemical data | |
Formula | C16H23NO2 |
Molecular mass | 261.37 g·mol−1 |
|
|
|
Isopropylphenidate (also known as IPH and IPPD) is a piperidine based stimulant drug, closely related to methylphenidate, but with the methyl ester replaced by an isopropyl ester. It has similar effects to methylphenidate but with a longer duration of action,[1][2] and was banned in the UK as a Temporary Class Drug from April 2015 following its unapproved sale as a designer drug.[3]
See also
References
- ↑ Markowitz JS, Zhu HJ, Patrick KS. Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability. Journal of Child and Adolescent Psychopharmacology. 2013 Dec;23(10):648-54. doi: 10.1089/cap.2013.0074. PMID 24261661
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Methylphenidate-based NPS: A review of the evidence of use and harm. Advisory Council on the Misuse of Drugs, 31 March 2015
Categories:
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Piperidines
- Dopamine reuptake inhibitors
- Stimulants
- Designer drugs